Myelin oligodendrocyte glycoprotein antibody-associated encephalitis after severe acute respiratory syndrome coronavirus 2 infection: a case report and retrospective case reviews.
Yoonkyung LeeSeon-Jae AhnHan-Sang LeeYongmoo KimSeolah LeeHyeyoung ParkJangsup MoonSang Kun LeeKon ChuPublished in: Encephalitis (Seoul, Korea) (2023)
Several cases of myelin oligodendrocyte glycoprotein (MOG) antibody-associated encephalitis have been reported after coronavirus disease 2019 (COVID-19). In this case, the patient presented with focal status epilepticus with impaired awareness, auditory hallucinations, and incoherent speech after COVID-19. Brain magnetic resonance imaging revealed no specific findings. Cerebrospinal fluid results showed pleocytosis and MOG antibody testing confirmed anti-MOG antibody with live cell-based fluorescence-activated cell sorting assay. The patient was diagnosed with MOG antibody-associated autoimmune encephalitis and treated with intravenous immunoglobulin, rituximab, and tocilizumab. This case occurred presumably due to auto-antibody production following COVID-19.
Keyphrases
- coronavirus disease
- respiratory syndrome coronavirus
- sars cov
- magnetic resonance imaging
- cerebrospinal fluid
- white matter
- rheumatoid arthritis
- stem cells
- case report
- randomized controlled trial
- computed tomography
- single cell
- low dose
- contrast enhanced
- high throughput
- bone marrow
- diffuse large b cell lymphoma
- diffusion weighted imaging
- mesenchymal stem cells
- subarachnoid hemorrhage
- resting state
- juvenile idiopathic arthritis
- meta analyses